Follow
Jaspreet Toor
Jaspreet Toor
Technical Analyst, Imperial College London
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
OJ Watson, G Barnsley, J Toor, AB Hogan, P Winskill, AC Ghani
The Lancet infectious diseases 22 (9), 1293-1302, 2022
12112022
Are we on our way to achieving the 2020 goals for schistosomiasis morbidity control using current World Health Organization guidelines?
J Toor, R Alsallaq, JE Truscott, HC Turner, M Werkman, D Gurarie, ...
Clinical Infectious Diseases 66 (suppl_4), S245-S252, 2018
1082018
Investigating the effectiveness of current and modified World Health Organization guidelines for the control of soil-transmitted helminth infections
SH Farrell, LE Coffeng, JE Truscott, M Werkman, J Toor, SJ de Vlas, ...
Clinical Infectious Diseases 66 (suppl_4), S253-S259, 2018
972018
Vaccine equity in low and middle income countries: a systematic review and meta-analysis
HA Ali, AM Hartner, S Echeverria-Londono, J Roth, X Li, K Abbas, ...
International journal for equity in health 21 (1), 82, 2022
832022
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world
J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ...
Elife 10, e67635, 2021
742021
Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation
J Toor, ER Adams, M Aliee, B Amoah, RM Anderson, D Ayabina, R Bailey, ...
Clinical Infectious Diseases 72 (8), 1463-1466, 2021
732021
The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
J Toor, HC Turner, JE Truscott, M Werkman, AE Phillips, R Alsallaq, ...
PLoS neglected tropical diseases 12 (10), e0006717, 2018
502018
Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
K Kura, D Ayabina, J Toor, TD Hollingsworth, RM Anderson
Transactions of The Royal Society of Tropical Medicine and Hygiene 115 (3 …, 2021
402021
Economic evaluations of mass drug administration: the importance of economies of scale and scope
HC Turner, J Toor, TD Hollingsworth, RM Anderson
Clinical infectious diseases 66 (8), 1298-1303, 2018
392018
Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
DV Ayabina, J Clark, H Bayley, PHL Lamberton, J Toor, TD Hollingsworth
PLoS neglected tropical diseases 15 (11), e0009083, 2021
362021
A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis
JE Truscott, D Gurarie, R Alsallaq, J Toor, N Yoon, SH Farrell, HC Turner, ...
Epidemics 18, 29-37, 2017
352017
Dynamics of SARS-CoV-2 with waning immunity in the UK population
T Crellen, L Pi, EL Davis, TM Pollington, TCD Lucas, D Ayabina, ...
Philosophical transactions of the royal society b 376 (1829), 20200274, 2021
342021
Testing for soil-transmitted helminth transmission elimination: Analysing the impact of the sensitivity of different diagnostic tools
M Werkman, JE Wright, JE Truscott, AV Easton, RG Oliveira, J Toor, ...
PLoS neglected tropical diseases 12 (1), e0006114, 2018
342018
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
J Toor, D Rollinson, HC Turner, A Gouvras, CH King, GF Medley, ...
The Journal of infectious diseases 221 (Supplement_5), S525-S530, 2020
322020
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
K Kura, JE Truscott, J Toor, RM Anderson
PLOS neglected tropical diseases 13 (6), e0007349, 2019
312019
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
K Kura, RJ Hardwick, JE Truscott, J Toor, TD Hollingsworth, RM Anderson
Parasites & Vectors 13, 1-10, 2020
252020
Economic evaluations of human schistosomiasis interventions: a systematic review and identification of associated research needs
HC Turner, MD French, A Montresor, CH King, D Rollinson, J Toor
Wellcome Open Research 5, 2020
252020
SCHISTOX: an individual based model for the epidemiology and control of schistosomiasis
M Graham, D Ayabina, TCD Lucas, BS Collyer, GF Medley, ...
Infectious Disease Modelling 6, 438-447, 2021
212021
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
J Toor, JE Truscott, M Werkman, HC Turner, AE Phillips, CH King, ...
Parasites & vectors 12, 1-7, 2019
212019
How can the public health impact of vaccination be estimated?
S Echeverria-Londono, X Li, J Toor, MJ de Villiers, S Nayagam, TB Hallett, ...
BMC Public Health 21, 1-12, 2021
202021
The system can't perform the operation now. Try again later.
Articles 1–20